President and Founder | Strategic Finance and Capital Markets Advisor @ KBZEE, LLC (October 2022 - Present)
Vice President Investor Relations and Corporate Communications (Acquired by Sanofi) @ Amunix Pharmaceuticals (November 2021 - September 2022)
Vice President Investor Relations and Corporate Strategy at Arcus Biosciences @ (April 2019 - November 2021)
Vice President Investor Relations and Corporate Communications @ (July 2018 - March 2019)
Senior Director Corporate Development and Investor Relations @ Nevro (December 2014 - July 2018)
Director Business Development @ Nevro (October 2013 - November 2014)
Senior Manager, Business Development @ Nevro (December 2012 - October 2013)
Senior Research Manager @ (November 2011 - December 2012)
Associate @ (August 2009 - October 2011)
Associate Market Planning Manager @ (April 2007 - July 2007)
Research Associate @ (August 2005 - March 2007)
Research Associate @ Corgentech (July 2002 - April 2005)
Katherine Bock Education
The Wharton School
MBA
2007-2009
San Francisco State University
Bachelor of Science - BS (Applied Mathematics)
2002
Katherine Bock Skills
Capital Markets
Corporate Strategy
Financial Modeling
Investor Relations
Katherine Bock Summary
Katherine Bock, based in Austin, TX, US, is currently a Senior Advisor, Biotechnology at Lucid Loop Technologies. Katherine Bock brings experience from previous roles at SilverLining, KBZEE, LLC, Amunix Pharmaceuticals and Arcus Biosciences. Katherine Bock holds a 2007 - 2009 MBA @ The Wharton School. With a robust skill set that includes Capital Markets, Corporate Strategy, Financial Modeling, Investor Relations and more. Katherine Bock has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Katherine Bock?
Find contact details for 700 million professionals.